Officials with the FDA have announced labeling changes to prescription opioid cough and cold medications that contain codeine or hydrocodone. As the age range has been changed for prescription opioid cough/cold products with this action, the FDA is recommending that healthcare professionals provide alternative treatments for children (ie, dextromethorphan, prescription benzonatate) when treatment of cough is necessary.
"We know that any exposure to opioid drugs can lead to future addiction", Gottlieb said. The contraindication - FDA's strongest warning - alerted patients that codeine should not be used to treat pain or cough in children younger than 12 years old, due to ultra-rapid metabolism being reported in patients.
The FDA says treating sick children with medicines that contain opioids poses "serious risks that don't justify their use".
Today's announcement follows an extensive review conducted by the FDA's Pediatric Advisory Committee on the benefits and risks associated with opioid antitussive use in pediatric patients.
Ingalls & Snyder LLC Has $24.29 Million Holdings in Johnson & Johnson (JNJ)
Cwh Capital Management Inc sold 2,526 shares as the company's stock rose 6.85% with the market. 6,828 were reported by Westpac Bk. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in JNJ.
Now, the FDA's latest action to revise safety labeling on some prescription cough and cold products expands the pediatric restrictions that were previously in place.
According to the agency, outside experts said that while some children's coughs require treatment, many get better on their own - including ones that are the result of respiratory infections. "Moreover, the risks of using prescription opioid cough products in children of all ages generally outweigh the potential benefits".
One physician who's dealt with the aftermath of opioid overuse applauded the move.
So what's the advice for parents who may be using these medicines for their child already?
Critical Comparison: Microsoft Corporation (MSFT) vs. CA, Inc. (CA)
Marsico Cap Mngmt Ltd has 0.11% invested in Microsoft Corporation (NASDAQ: MSFT ). 124,933 were reported by Private Company Na. Microsoft Corporation's P/B is valued at 7.35 exhibiting the investor sentiment on the value of the stock to its actual value.
It's always important to read medicine labeling, too - even if it's not obtained by prescription.
In 2015, the FDA also announced an investigation into the possible risks of using codeine-containing medicines to treat coughs and colds in children under 18.
There's more about this issue at the American Academy of Pediatrics.
2 bodies recovered from burning oil tanker in China
The stricken tanker, Sanchi , had drifted into Japan's exclusive economic zone and "suddenly ignited", reports said . All 32 sailors on board an oil tanker that sank after burning for a week have been confirmed dead .